Evidence map›Paper›PMID 37087579›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2023

[Chemical reprogramming of human embryonic fibroblasts into neural progenitor cells

P Yang, Y Wang, Q Gao, Y Liu, Y Wang, Y Guo, C Liu, G Liu

Abstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

P YangBengbu Medical College School of Life Sciences, Bengbu 233000, China.
Y WangBengbu Medical College School of Life Sciences, Bengbu 233000, China.
Q GaoBengbu Medical College School of Life Sciences, Bengbu 233000, China.
Y LiuBengbu Medical College School of Life Sciences, Bengbu 233000, China.
Y WangBengbu Medical College School of Life Sciences, Bengbu 233000, China.
Y GuoBengbu Medical College School of Laboratory Medicine, Bengbu 233000, China.
C LiuBengbu Medical College School of Life Sciences, Bengbu 233000, China.
G LiuBengbu Medical College School of Life Sciences, Bengbu 233000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo establish a protocol for reprogramming human embryonic fibroblasts (HEFs) into chemically induced neural progenitor cells (ciNPCs).

methodsIn the two-staged reprogramming of HEFs, the intermediate compact cell colonies were first chemically induced in KSR medium containing small-molecule compounds (VCR) for 15 days in normoxia, followed by the lineage-specific induction stage, in which the compact cell colonies were digested with 0.25% trypsin and the cells were cultured in low adhesion plates. After formation of a large number of free-floating neurospheres 2 days later, the ciNPCs were labeled with CM-DiI and transplanted into rat models of Parkinson's disease (PD)to observe the survival, migration and differentiation of the cells in PD brain.

resultsAfter induction with VCR for 10 days under normoxic condition, compact cell colonies occurred in HEF cultures (approximately 40 colonies in each well containing 1×10

conclusionHEFs can be directly reprogrammed into ciNPCs using smallmolecule compounds without the need of introducing exogenous genes. This success may provide a solution to the shortage of donor materials for neuroscience research and treatment of neurodegenerative diseases.

Indexed as

Neural Stem CellsAnimalsCell DifferentiationCells, CulturedFibroblastsHumansNeuronsRatscell reprogramminghuman embryonic fibroblastsneural progenitor cellssmall molecule compounds

Identifiers

PMID37087579
PMCPMC10122728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.